OBJECTIVES: To investigate the clinimetric properties and clinical utility of the AsTex((R)), a new clinical tool for evaluation of hand sensation following stroke. DESIGN: The AsTex((R)) was administered on two occasions separated by a week to appraise test-retest reliability, and by three assessors on single occasion to establish inter-rater reliability. Pilot normative values were collected in an age-stratified sample. Clinical utility was evaluated based on ease of administration, ceiling and floor effects, and responsiveness to sensory recovery. PARTICIPANTS: Test-retest (n = 31) and inter-rater (n = 31) reliability and normative values (n = 95) for the AsTex((R)) were established in neurologically normal participants aged 18-85 years. Test-retest reliability was investigated in 22 individuals a mean of 46 months (range 12-125) post stroke and clinical utility was evaluated in an additional 24 subacute stroke participants a mean of 29.4 days (range 12-41) post stroke. MAIN MEASURE: The AsTex((R)). RESULTS: The AsTex((R)) demonstrated excellent test-retest (intraclass correlation coefficient (ICC) = 0.98, 95% confidence interval (95% CI) = 0.97-0.99) and inter-rater reliability (ICC = 0.81, 95% CI = 0.73-0.87) in neurologically normal participants. Test-retest reliability of the AsTex((R)) in individuals following stroke was excellent (ICC = 0.86, 95% CI = 0.68-0.94). The AsTex((R)) was simple to administer, demonstrated small standard error of measurement (0.14 mm), minimal floor and ceiling effects (12.5% and 8.3%) and excellent responsiveness (standardized response mean = 0.57) in subacute stroke participants. CONCLUSION: The AsTex((R)) is a reliable, clinically useful and responsive tool for evaluating hand sensation following stroke.
OBJECTIVES: To investigate the clinimetric properties and clinical utility of the AsTex((R)), a new clinical tool for evaluation of hand sensation following stroke. DESIGN: The AsTex((R)) was administered on two occasions separated by a week to appraise test-retest reliability, and by three assessors on single occasion to establish inter-rater reliability. Pilot normative values were collected in an age-stratified sample. Clinical utility was evaluated based on ease of administration, ceiling and floor effects, and responsiveness to sensory recovery. PARTICIPANTS: Test-retest (n = 31) and inter-rater (n = 31) reliability and normative values (n = 95) for the AsTex((R)) were established in neurologically normal participants aged 18-85 years. Test-retest reliability was investigated in 22 individuals a mean of 46 months (range 12-125) post stroke and clinical utility was evaluated in an additional 24 subacute strokeparticipants a mean of 29.4 days (range 12-41) post stroke. MAIN MEASURE: The AsTex((R)). RESULTS: The AsTex((R)) demonstrated excellent test-retest (intraclass correlation coefficient (ICC) = 0.98, 95% confidence interval (95% CI) = 0.97-0.99) and inter-rater reliability (ICC = 0.81, 95% CI = 0.73-0.87) in neurologically normal participants. Test-retest reliability of the AsTex((R)) in individuals following stroke was excellent (ICC = 0.86, 95% CI = 0.68-0.94). The AsTex((R)) was simple to administer, demonstrated small standard error of measurement (0.14 mm), minimal floor and ceiling effects (12.5% and 8.3%) and excellent responsiveness (standardized response mean = 0.57) in subacute strokeparticipants. CONCLUSION: The AsTex((R)) is a reliable, clinically useful and responsive tool for evaluating hand sensation following stroke.
Authors: Roslyn N Boyd; Jenny Ziviani; Leanne Sakzewski; Laura Miller; Joanne Bowden; Ross Cunnington; Robert Ware; Andrea Guzzetta; Richard Al Macdonell; Graeme D Jackson; David F Abbott; Stephen Rose Journal: BMC Neurol Date: 2013-06-28 Impact factor: 2.474
Authors: Asif Hussain; Sivakumar Balasubramanian; Nick Roach; Julius Klein; Nathanael Jarrassé; Michael Mace; Ann David; Sarah Guy; Etienne Burdet Journal: J Rehabil Assist Technol Eng Date: 2017-09-18
Authors: Carolee J Winstein; Steven L Wolf; Alexander W Dromerick; Christianne J Lane; Monica A Nelsen; Rebecca Lewthwaite; Sarah Blanton; Charro Scott; Aimee Reiss; Steven Yong Cen; Rahsaan Holley; Stanley P Azen Journal: BMC Neurol Date: 2013-01-11 Impact factor: 2.474
Authors: Roslyn N Boyd; Emmah Baque; Adina Piovesana; Stephanie Ross; Jenny Ziviani; Leanne Sakzewski; Lee Barber; Owen Lloyd; Lynne McKinlay; Koa Whittingham; Anthony C Smith; Stephen Rose; Simona Fiori; Ross Cunnington; Robert Ware; Melinda Lewis; Tracy A Comans; Paul A Scuffham Journal: BMC Neurol Date: 2015-08-19 Impact factor: 2.474